| PDF (152kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-268543
- DOI to cite this document:
- 10.5283/epub.26854
Abstract
Ketanserin, which preferentially blocks 5-HT2-serotonergic receptors, was injected intravenously (i.v.) to patients with congestive heart failure in a bolus dose of 10 mg, followed by an i.v. infusion of 3 mg/h over a period of 4 h. The drug caused a decrease in total peripheral resistance and, conversely, an increase in stroke volume. Right atrial and pulmonary artery pressures were decreased. ...
Owner only: item control page